HTSUY (Hisamitsu Pharmaceutical Co) FFO


HTSUY Hisamitsu Pharmaceutical Co Inc HTSUY
84 GF Score
Price $2.94
GF Value $2.39
Valuation Significantly Undervalued
View Full Analysis

What is Hisamitsu Pharmaceutical Co FFO?

FFO (Funds from operations) only applies to REITs.

HTSUY
84GF Score
Hisamitsu Pharmaceutical Co Inc HTSUY
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Hisamitsu Pharmaceutical Co (HTSUY) Overvalued in 2026?

Based on GuruFocus' analysis, Hisamitsu Pharmaceutical Co stock appears to be overvalued. The current stock price of $2.94 is trading 23% above its estimated GF Value™ of $2.39. GuruFocus considers Hisamitsu Pharmaceutical Co to be Significantly Undervalued.

Key valuation signals for HTSUY:

  • FFO:
  • GF Value™: $2.39 vs. price of $2.94 (23% above fair value)
  • GF Score™: 84/100

No single metric tells the full story. See the HTSUY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hisamitsu Pharmaceutical Co Business Description

Address 408 Tashiro Daikancho, Saga Prefecture, Tosu, JPN, 841-0017
Hisamitsu Pharmaceutical Co Inc is engaged in the research, development, manufacturing, procurement, and sale of pharmaceutical products. The company operates a single business segment, focusing on medical and general pharmaceuticals both in Japan and overseas. It markets drugs under the Salonpas, Nobinobi / Salonsip, Butenalock, and Mohrus brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions, and ointments.
84GF Score

Get the complete analysis for HTSUY

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.94
Price
$2.39
GF Value